Sublocade is designed to last for about one month per injection because it slowly releases buprenorphine over time, which is why it is given as a once-monthly treatment by a healthcare provider. In standard dosing, patients usually start with two 300 mg injections, then continue with monthly maintenance dosing, most often 100 mg, with at least 26 days between doses. 

For many people, the bigger question is not just how long Sublocade stays active in the body, but how the monthly dosing process supports recovery. Sublocade can remain detectable for months after treatment stops, but its treatment schedule is built around steady month-to-month medication levels rather than daily dosing.

For a recovery center audience, the most helpful way to explain sublocade is simply: it is a long-acting monthly injection of buprenorphine used to treat moderate to severe opioid use disorder as part of a broader treatment plan that includes counseling and psychosocial support. Instead of taking medication every day, patients receive an injection from a provider, and the medication is released gradually across the month.

That monthly structure is often appealing to patients and families because it can reduce the pressure of daily medication routines while giving providers a clear schedule for follow-up, symptom review, and treatment planning. At the same time, understanding how long sublocade lasts also means understanding what happens during startup, why the first months matter, what happens if a dose is delayed, and why treatment length can vary from one person to another.

How long does Sublocade actually last after one injection?

When people ask how long sublocade lasts, they usually mean one of two things: how long the medication actively works, and how long it remains in the body. For treatment purposes, each injection is intended to cover roughly one month. That is why the medication is scheduled as a once-monthly injection rather than a daily dose. The medication is released gradually over time, which helps create more stable buprenorphine levels across the month instead of the day-to-day swings some patients associate with short-acting medication routines.

This monthly design matters because recovery often improves when treatment feels consistent and predictable. A patient does not need to remember a pill or film every morning. Instead, the treatment plan moves into a provider-managed schedule. That can support adherence, reduce missed daily doses, and make it easier for a care team to monitor how well symptoms such as cravings and withdrawal are being controlled. It also gives patients more room to focus on counseling, routines, and behavioral recovery work rather than the mechanics of taking medication every day. 

It is also important to separate “lasting a month” from “leaving the system.” The clinical effect is designed around monthly dosing, but buprenorphine from sublocade can remain detectable long after treatment stops. That does not mean every patient feels the medication the same way for the same amount of time, but it does mean the drug has an extended-release profile that continues beyond the visible monthly appointment cycle. For patients and families, the practical takeaway is simple: each injection is intended to support the next month of treatment, while the medication itself may linger much longer in the body.

Related: Is Sublocade Right for You? What Patients Should Know Before Starting

Why is Sublocade given monthly instead of daily?

Sublocade is given monthly because it was designed to release buprenorphine slowly and steadily over time. That steady-release approach can help patients avoid the burden of taking medication every day, while still receiving ongoing treatment support for opioid use disorder. From a care perspective, monthly dosing also creates a structured rhythm for check-ins, symptom review, and adjustment of the treatment plan when needed.

For many patients, the emotional value of monthly treatment is just as important as the pharmacology. Daily medications can become a constant reminder of illness, especially for someone trying to rebuild routines, return to work, repair family relationships, or create more stability at home. A monthly injection can reduce that daily decision-making load. It does not remove the need for active recovery work, but it can make medication management feel less intrusive. This is one reason treatment centers often describe sublocade as a tool that allows people to focus more energy on recovery itself. 

There is also a clinical reason the monthly schedule is closely managed. Sublocade is administered only by a healthcare provider and is intended to be part of a full treatment plan that includes counseling and psychosocial support. The process is not only about delivering medication; it is also about ongoing assessment. Providers can use each visit to evaluate cravings, withdrawal symptoms, side effects, recovery progress, and the overall fit of the medication plan. In other words, the monthly model helps combine medication stability with regular professional oversight. For patients who need a treatment approach that is steady, structured, and less dependent on daily self-administration, that can be a meaningful advantage.

Related: When Sadness Becomes Depression: Knowing When to Seek Help

What does the first month of Sublocade treatment look like?

The first month of sublocade treatment is usually more structured than patients expect, and that is a good thing. Starting treatment safely matters. According to the prescribing information, patients who are not already taking buprenorphine should first receive an initial transmucosal buprenorphine dose to confirm tolerability before the first Sublocade injection. For patients already stabilized on daily transmucosal buprenorphine, the transition process may be more direct. Either way, the goal is to begin treatment in a way that reduces complications and gives providers a chance to monitor the response.

The first injection is typically 300 mg. After that, the second injection is also generally 300 mg and may be given as early as one week after the first injection, depending on patient need, though the broader schedule still functions as a monthly treatment model. This startup phase is important because it helps establish therapeutic medication levels before the patient moves into maintenance treatment. Patients and families sometimes hear “monthly” and assume every injection must happen exactly 30 days apart from day one, but the initial treatment phase is more flexible than that because the priority is stabilization.

What often helps patients most during this first month is knowing what to expect:

• The injection is administered by a healthcare provider, not self-administered at home.
• The medication is injected under the skin and forms a depot that releases buprenorphine over time.
• Providers monitor how symptoms are responding, especially early on.
• Counseling and psychosocial support should continue alongside medication.

For a recovery center website, this is often the most reassuring message: the first month is not just about receiving an injection. It is about creating a stable foundation. The medication, provider supervision, and counseling framework are meant to work together so the patient has the strongest possible start.

Related: Understanding PTSD: Symptoms, Causes, and Effective Treatments

How does the standard Sublocade dosing schedule work over time?

Once the initiation phase is complete, the sublocade dosing schedule becomes easier to understand. The standard pattern is two initial 300 mg injections, followed by monthly maintenance dosing that is usually 100 mg. For some patients, a monthly 300 mg maintenance dose may be considered if they tolerate 100 mg but do not have a satisfactory clinical response. Maintenance injections should be administered at least 26 days apart. 

This is where many patients start to feel the practical benefit of treatment consistency. Instead of managing medication every day, they move into a predictable monthly appointment cycle. That can help providers and patients notice patterns more clearly. Are cravings controlled? Is the patient reporting breakthrough withdrawal symptoms? Is recovery becoming more stable in daily life? Monthly maintenance makes it easier to evaluate these questions over time rather than reacting to day-by-day fluctuations. 

It is also important to remember that not every patient follows the exact same experience even when the dosing framework is the same. One person may do very well on maintenance at 100 mg, while another may need closer reassessment because symptoms are not adequately controlled. The monthly process allows for clinical decision-making without turning treatment into guesswork. In recovery care, that balance matters. A treatment schedule should be structured enough to be reliable, but flexible enough to match real patient needs. That is one reason the dosing process is provider-managed rather than self-directed. The key message for patients is that sublocade is not a one-size-fits-all shortcut. It is a long-acting medication with a standard monthly framework and room for individualized treatment decisions along the way.

Related: Suboxone Success: Why It Works for So Many in Recovery

What happens if a patient misses or delays a dose?

Missing a dose can feel alarming to a patient or family, but the prescribing information gives providers a clear path. A missed maintenance dose should be given as soon as possible, with the following dose administered at least 26 days later. The label also notes that occasional delays in dosing of up to two weeks are not expected to have a clinically significant impact on treatment effect.

That does not mean patients should become casual about timing. Monthly treatment works best when appointments are kept consistently. Still, this guidance is reassuring because it reflects the extended-release nature of sublocade. Since the medication is designed to provide steady coverage over time, a brief delay does not automatically mean a patient has lost all treatment benefits. In practice, the right response is usually to contact the treatment provider promptly, reschedule, and continue under the provider’s instructions rather than panic or assume the medication has completely worn off. 

There are also special circumstances built into the labeling. For patients established on 100 mg monthly, there may be situations, such as extended travel, when a single 300 mg dose may be used to cover a two-month period, after which the 100 mg monthly schedule resumes. That is not something patients should plan on their own, but it shows that the dosing process can accommodate real-life needs when managed appropriately by a clinician.

The most useful way to explain missed doses to a treatment audience is this:

1. Try to stay on the regular monthly schedule whenever possible. 
2. If a dose is missed, contact the provider and receive the next dose as soon as possible.
3. Do not make independent dosing decisions or assume the plan should change without medical guidance.
4. Understand that brief delays may be manageable, but consistency still supports the best treatment outcomes.

How long do people usually stay on Sublocade treatment?

One of the most important things patients should know is that there is no single universal timeline for how long someone stays on sublocade. The prescribing information states that there is no maximum recommended duration of maintenance treatment and that, for some patients, treatment may continue indefinitely. That reflects the reality of opioid use disorder: it is a chronic condition, and medication decisions should be based on clinical stability, relapse risk, recovery progress, and the individual patient’s needs. 

This can be difficult for families who want a simple answer such as “three months” or “six months.” In real-world treatment, duration is rarely that neat. Some patients benefit from a longer period of medication support while they build routines, strengthen counseling engagement, and reduce relapse risk. Others may eventually reach a point where the care team evaluates whether continuing, tapering, or transitioning treatment makes sense. What matters is that the decision is based on recovery stability rather than pressure, stigma, or an arbitrary deadline.

Another reason treatment duration must be individualized is that sublocade has extended-release characteristics that continue even after discontinuation. The label recommends monitoring patients for several months after stopping treatment for signs and symptoms of withdrawal, and it notes that after steady state is achieved, buprenorphine may remain detectable for 12 months or longer. That does not mean treatment never ends; it means ending treatment should be approached thoughtfully and under medical supervision. For a recovery center website, the clearest message is also the most honest: the right treatment length is the one that best supports long-term recovery, safety, and stability for the individual patient. 

FAQ

Is Sublocade a daily medication?
No. Sublocade is a once-monthly injection administered by a healthcare provider, and it is designed to release medication gradually over the month.

Does Sublocade stop working immediately after a month?
Not abruptly. It is scheduled monthly for treatment purposes, but the medication has extended-release properties and can remain in the body long after the injection date passes. 

Can someone stay on Sublocade long term?
Yes. There is no maximum recommended duration of maintenance treatment, so length of care depends on the patient’s clinical needs and recovery progress.

What happens if I miss a Sublocade injection?
A missed dose should be scheduled as soon as possible. Your provider will adjust the schedule safely to maintain treatment effectiveness.

Is Sublocade covered by Medicaid?
In many cases, Medicaid covers Sublocade treatment, though approval requirements may apply. A provider can assist with insurance verification.

If you or a loved one is exploring treatment options like sublocade, the team at Revival Recovery Center is here to help you navigate every step with clarity and compassion. Located in Highland, Michigan, Revival Recovery Center provides personalized, evidence-based care designed to support long-term recovery.

You’ll be guided by experienced professionals, including Lisa Perna, a board-certified nurse practitioner specializing in addiction medicine and behavioral health, ensuring you receive expert, individualized treatment.

For added convenience and accessibility, Revival Recovery Center also offers Virtual Appointments in Brighton, Michigan, making it easier to begin or continue care from the comfort of your home.

Reach out today to learn how sublocade and comprehensive support can help you or your loved one move forward with confidence.